U.S. FDA grants emergency use authorization for Novavax COVID-19 vaccine
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
Plant is part of the company's CAD $30 million capital investment in the site
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
Site Enhances New Modality CRDMO Platform Capacity for Customers
Krsnaa Diagnostics now has its footprints in Delhi.
Subscribe To Our Newsletter & Stay Updated